Dismal outcomes of patients with relapsed/refractory Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia after failure of both inotuzumab ozogamicin and blinatumomab

Research output: Contribution to journalLetterpeer-review

4 Scopus citations
Original languageEnglish (US)
Pages (from-to)E201-E204
JournalAmerican journal of hematology
Volume97
Issue number6
DOIs
StatePublished - Jun 1 2022

ASJC Scopus subject areas

  • Hematology

Cite this